CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease-Meta-Analysis and Meta-Regression of Randomized Trials 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines In-Hospital Coronary Revascularization Rates and Post-Discharge Mortality Risk in Non–ST-Segment Elevation Acute Coronary Syndrome Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials Ticagrelor versus Clopidogrel in Patients with STEMI Treated with Fibrinolytic Therapy: TREAT Trial Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up Study Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice : An NCDR Registry to Practice Project Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial
|<<... 27 28 29 30 31 32 33 ...>>|

JOURNAL：CBS2017 Article Link

CBS exhibits at EuroPCR 2017 in Paris

CBS2017

Paris, France - Starting from May 16, Left Main & Coronary Bifurcation Summit (CBS) will present the next congress plan at EuroPCR 2017 in Paris. An on-site platform for treatment against left main and coronary bifurcation lesions will be located on the third floor of the Palais des Congrès. All participants and cardiovascular experts are welcomed to CBS booth stand H9 during this 4-day meeting.

On the 10th Summit in this winter, CBS will continue the concept of patient-centric care. Discussion on the objectives like applying big data with well designed RCT to obtain more clinical evidence, incorporation of new interventional technologies and treatment options, integration of hemodynamic evaluation and mechanisms into the treatment, analysis and comparison of treatment options will be put on extra weight. CBS2017 will be helpful to make a comprehensive and in-depth academic exploration on the issue of left main and coronary bifurcation disease.

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top